Sihuan Pharmaceutical Holdings Group Catalyst Calendar
Proactively evaluate Sihuan Pharmaceutical Holdings Group Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Sihuan Pharmaceutical Holdings Group Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
01 Jul 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
24 Jun 2020 | Phase III Trial Completion | Sihuan Pharmaceutical Holdings Group Ltd | 460 | Janagliflozin | Metabolic Disorders | Type 2 Diabetes | Clinical Trial Registry |
30 Apr 2020 | Phase III Trial Completion | Sihuan Pharmaceutical Holdings Group Ltd | 460 | Janagliflozin | Metabolic Disorders | Type 2 Diabetes | Clinical Trial Registry |
31 Dec 2019 | Phase I Trial Completion | Jilin Jinsheng Pharmaceutical Co Ltd; West China Hospital of Sichuan University | - | insulin aspart | Metabolic Disorders | Diabetes | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer